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Abstract
Coronary chronic total occlusions (CTOs) represent the most technically challenging lesion subset that interventional
cardiologists face. CTOs are identified in up to one third of patients referred for coronary angiography and remain
seriously undertreated with percutaneous techniques. The complexity of these procedures and the suboptimal success
rates over a long period of time, along with the perception that CTOs are lesions with limited scope for recanalization,
account for the underutilization of CTO Percutaneous Coronary Intervention (PCI). During the last years, dedicated
groups of experts in Japan, Europe and United States fostered the development and standardization of modern CTO
recanalization techniques, achieving success rates far beyond 90 %, while coping with lesions of increasing complexity.
Numerous studies support the rationale of CTO revascularization following documentation of viability and ischemia in
the territory distal to the CTO. Successful CTO PCI provide better tolerance in case of future acute coronary syndromes
and can significantly improve angina and left ventricular function. Randomized trials are on the way to further explore
the prognostic benefit of CTO revascularization. The following review reports on the theory and the most recent
advances in the field of CTO recanalization, in an attempt to promote a more balanced approach in patients with
chronically occluded coronary arteries.
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Background
Coronary Chronic Total Occlusions (CTOs) are identified
in up to one third of patients with coronary artery disease
referred for coronary angiography [1–3], with an inci-
dence increasing with age [4]. Numerous studies support
the rationale of CTO recanalization in case of docu-
mented viability and ischemia in the territory distal to the
CTO. Successful CTO recanalization is related to im-
proved survival, improvement in anginal status and left
ventricular function, increased exercise tolerance, de-
creased need for Coronary Artery Bypass Grafting
(CABG) and better tolerance of future acute coronary
syndromes [5–9]. Recent series report that successful
CTO Percutaneous Coronary Intervention (PCI) might
also reduce the risk for arrhythmic events in patients
with ischemic cardiomyopathy [10].
The success rates of operators experienced in conven-
tional CTO PCI techniques was never greater than 60–
70 % [6], considerably lower than the success rates in
non-occlusive coronary artery disease. Restenosis and
reocclusion were also high before the introduction of
Drug Eluting Stents (DES) [11]. Randomized trials ex-
ploring the prognostic benefit of CTO revascularization
have not been launced until recently and are still recruit-
ing. No more than 10 % of all CTOs have been treated
with percutaneous techniques over a long period of time,
with the majority of patients primarily managed medic-
ally or referred for CABG [1, 4, 12–15]. Lesions with se-
vere tortuosities, calcifications or large bifurcations present
technical challenges, but currently dedicated centers apply-
ing new strategies achieve success rates far above 90 % [16].
The following review reexamines the evidence leading to
the underutilization of CTO revascularization procedures,
promoting a more balanced and proactive approach in pa-
tients suffering of this often highly disabling condition.
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Definition
A chronic total occlusion is defined as an angiographically
documented or clinically suspected complete interruption
of antegrade coronary flow (Thrombolysis In Myocardial
Infarction-TIMI- 0 flow) of greater than 3 months stand-
ing [17]. Occasionally, bridging collaterals may provide
antegrade flow to the vessel beyond the occlusion, giving
the false impression of a functional sub-occlusive lesion.
Careful examination of the occlusion in multiple views de-
lineates the position of these collaterals outside the vessel
architecture. The interpretation is often complicated by
the presence of intraluminal microchannels, which are
demonstrated pathologically in the majority of cases, and
may play a role in facilitating wire crossing [18, 19], but
mostly remain below the resolution of angiography
(100 μm) and do not generally traverse the entire occluded
segment or they violate the TIMI 0 criterion [20, 21].
Prevalence
The prevalence of CTOs depends on the type of patients
studied with an incidence ranging between 10 and 30 %
of all coronary angiograms [1–3]. A history of myocar-
dial infarction can be elicited in 30–50 % of the patients
undergoing CTO PCI [6, 22], suggesting acute onset of
the occlusion, whereas in the remaining patients gradual
development of CTO likely occurred. Interestingly, Choi
et al. utilizing magnetic resonance imaging in 170 con-
secutive patients with coronary CTO revealed evidence
of prior MI by late gadolinium enhancement in 86 % of
patients, a much higher proportion that previously rec-
ognized, with only 25 % of patients showing Q-waves on
their electrocardiogram [23]. More recent reports tend
to show a lower CTO prevalence, possibly explained by
the universal use of primary angioplasty and early revas-
cularization in acute coronary syndromes. Still, silent is-
chemia or presence of atypical symptoms misinterpreted
at the time of the acute event account for the consistent
persistence of CTOs in 18.4 % of patients even in the
most recent series [1]. CTOs are identified in more than
50 % of patients restudied after CABG [1], with this sub-
group of patients suffering lower technical success rates
during native coronary occlusion recanalization com-
pared to patients without prior CABG [24, 25]. You may
expect that in patients with acute coronary syndromes
CTOs are less frequent. In reality, even in patients with
acute ST segment elevation myocardial infarction
(STEMI), the incidence is 13 % [26], with this subgroup
of patients suffering a particularly poor immediate and
long-term prognosis. The presence of a CTO in a non-
infarct related artery was found to be a strong and inde-
pendent predictor for both early mortality (within 30 days
after STEMI) and late mortality (from 30 days to 5 years
after STEMI) [26, 27]. Inability to provide collaterals to
the occluded vessel and, vice versa, acute impairment of
preexisting collaterals from the acutely occluded vessel
to the CTO jeopardizing a large myocardial territory are
possible explanations of this phenomenon, which prob-
ably also explains the prognostic benefit of recanalizing
CTOs. Interestingly, Valenti et al. recently reported
that staged CTO revascularization in patients under-
going primary PCI is associated with improved one
year (1.7 vs 12 % in non-attempted or failed CTO-PCI
group, p 0.025) and three-year cardiac survival [28].
Pathology of chronic total occlusions
The basic pathological feature of a CTO consists firstly
of a proximal cap, which is often fibrotic or calcified and
either of tapering type or not. The body of the occlusion
in the majority of CTOs has some degree of neovascu-
larization and is composed of loose or dense fibrous tis-
sue, atheroma, calcified tissue and focal lymphocyte
infiltrate [19, 21]. Sakakura et al. in a recent autopsy
series revealed that negative occlusion remodeling was
frequent and particularly increased in long-standing
CTOs; shorter duration CTOs demonstrated abundant
organized thrombus and large necrotic core and CTOs
with CABG were severely calcified [29]. The distal cap
of the occlusion, opacified via the collateral circulation
during injection in most cases, appears to have more fre-
quently tapered morphology than the proximal cap (78.9
vs 48.4 % in a recent series), facilitating distal wire entry
with the retrograde techniques [29].
Collateral circulation in chronic total occlusions
Collaterals are interarterial connections that provide
blood flow to a vascular territory whose original supply
is compromised. They develop driven by shear forces
along the pressure gradient through the recruitment of
pre-existing interarterial connections and preserve to a
variable extent the integrity of the territory supplied by
the obstructed vessel. Some of these connections may be
preformed to such an extent that they are immediately
recruitable during vessel occlusion [30] and may even
prevent a myocardial infarction when an occlusion
develops gradually; yet, the presence of viability is not a
prerequisite for collateral development. Collaterals gen-
erally require 2–12 weeks to fully develop their func-
tional capacity and mostly remain below angiographic
resolution (200 μm) [31].
Rentrop et al. in 1985 described an angiographic grad-
ing system that does not rate the collaterals channels
themselves, but their effect in filling the occluded arterial
segment (grade 0 = no collaterals; grade 1 = side branch
filling of the recipient artery without filling of the main
epicardial artery; grade 2 = partial filling of the main epi-
cardial recipient artery; grade 3 = complete filling of the
main epicardial recipient artery) [32]. Werner et al. in
2003 introduced a novel classification of the collateral
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circulation, essential for the assessment of collateral
access in contemporary retrograde techniques, that was
validated with reference to physiologic measures of
collateral function (CC grade 0 = no continuous connec-
tion between collateral supplying and receiving vessel;
CC1 = threadlike continuous connection; CC2 = side
branch-like connection; CC3 > 1 mm diameter of direct
connection - not included in the original description) [31].
The functional supply of even angiographically well-
developed collaterals to the occluded arterial segment is
by definition suboptimal, with less than 10 % of the
collateral channels achieving a normal coronary flow re-
serve during pharmacological stress [33]. The high
prevalence of coronary steal in CTOs indicates that pa-
tients with even well collateralized CTOs may benefit
from a revascularization [33].
CTO revascularization results in the regression of the
collaterals through a process starting immediately after
the re-establishment of antegrade flow and extending
further many months after the revascularization proced-
ure. Acute reocclusion would therefore lead to an acute
coronary syndrome in most cases, as the recruitment of
collaterals is not instantaneous in most patients [34–36].
Rationale and indication for CTO recanalization
Relief of symptomatic ischemia and angina and improve-
ment of prognosis are the ultimate goals of CTO revas-
cularization. The problem with symptoms related to a
CTO is their often-atypical presentation that, along with
the chronic nature of the situation, may lead patients to
adapt to their limited exercise capacity and often deny
typical angina and only report dyspnea at higher exercise
levels. Still, there is substantial evidence from non-
randomized reports and prospective registries to relate
successful CTO recanalization with improved angina-
related quality of life, most pronounced in patients with
a symptomatic state before PCI [37–40].
Randomized data to support improvement of Left Ven-
tricle (LV) function following successful CTO recanaliza-
tion are not available. A number of observational studies,
reporting from an era prior widespread DES utilization,
revealed LV functional improvement following successful
CTO PCI, with the effect on regional function generally
more pronounced than the effect on global LV function as
assessed by Ejection Fraction (EF) [41–43]. In the case of
documented ischemia related regional impairment, func-
tional recovery starts within 1 to 4 weeks after revasculari-
zation and is usually extends through 3 months post the
index procedure [44–46]. Imaging techniques are most
suitable to detect the presence of hibernating or stunned
but viable myocardium. Magnetic Resonance Imaging
(MRI) is the gold standard to detect pharmacologically-
induced wall motion changes, precisely assessing myocar-
dial fibrosis, perfusion and viability [47]; subendocardial
extent of the late gadolinium enhancement smaller than
50 % of the wall thickness and reversible perfusion deficit
greater than 10 % of the total myocardial mass with myo-
cardial nuclear perfusion are currently used as gold stan-
dards for viability and prognostically relevant ischemia.
The prognostic impact of successful CTO recanalization
remains under debate. A number of non-randomized
series report favorable long-term outcome and decreased
need for CABG on patients undergoing successful CTO
PCI, but generally reflect an era non comparable to today’s
standard of treatment [5–7, 48–52]. Of note, the target
vessel seems to affect the prognostic outcome with a
recent series reporting improved long-term survival with
successful PCI of a CTO in the LAD and the LCX, but
not the RCA [53]. Multicenter randomized trials, such as
DECISION-CTO (NCT01078051) and EURO-CTO
(NCT01760083), have been launched to further elucidate
the prognostic impact of CTO revascularization [17]. In
anticipation of those studies’ results, the indications to re-
vascularization of CTOs should not differ from the indica-
tions to revascularization of subocclusive lesions and can
be defined based on a potential improvement of prognosis.
There is a considerable amount of data supporting the re-
vascularization of coronary lesions causing silent ischemia
of more than 10 % of myocardial volume; this applies also
to CTOs with documented ischemia and viability in the
territory supplied by the occluded vessel [17, 54, 55].
Several studies reported the adverse impact of incomplete
revascularization on subsequent clinical outcomes [56,
57]. In the Synergy Between Percutaneous Coronary Inter-
vention with Taxus and Cardiac Surgery (SYNTAX) trial,
angiographic complete revascularization was achieved in
only 52.8 % of the PCI patients, with the presence of a
total occlusion being the strongest independent predictor
of incomplete revascularization [57].
The dimension of the occluded artery and the pres-
ence of other critically narrowed arteries weigh heav-
ily in the decision to revascularize a CTO. Patients
with poorly controlled anginal symptoms with medical
therapy may also have indications to revascularization
[58]. A prerequisite to meet this indication is the
optimization of the dose and type of drugs, starting
from beta-blockers, and the demonstration of object-
ive evidence of ischemia. In theory, indications to sur-
gery or angioplasty are based on the same criteria and
the decision between one or the other is purely tech-
nical; surgical revascularization may be favored in the
presence of left main coronary artery disease, complex
triple vessel disease (especially in patients with comor-
bidities such as insulin-dependent diabetes, severe left
ventricular dysfunction or chronic renal insufficiency),
occluded proximal left anterior descending artery and
multiple CTOs with a relatively low anticipated suc-
cess rate [59].
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Lesion characteristics
Lesion characteristics play an important role in the
likelihood of successful CTO recanalization. Several
studies-nonreflecting contemporary CTO PCI practice-
have consistently reported that increasing age of the oc-
clusion, presence of calcium, presence of a non-tapered
stump, excessive tortuosity of occluded vessels, long oc-
clusion length, side branches at the occlusion entry, bridg-
ing collaterals, and lack of visibility of path in the distal
vessel predispose to technical failure [50, 60–62]. Increas-
ing operator experience along with antegrade technique
evolution increased procedural success rates from 60–70
to 80 %, limiting at the same time the traditional predict-
ive factors of failure to two: occlusion length and severe
calcification. Morino et al. in 2011 introduced a lesion-
related difficulty-grading tool, the J-CTO score, based on
a large series of antegrade recanalizations in Japan [63].
Length greater than 20 mm, presence of a greater than 45°
bend within the occlusion, presence of intralesional calcifi-
cation, delineation of a stump at the proximal end are four
angiographic parameters shown to influence the success
rate and time requested for anterograde recanalization.
With the addition of a fifth parameter derived from the
clinical history, a previous failed attempt, it is possible to
calculate the J-CTO score attributing to each of these pa-
rameters one point. “Easy” lesions with a score of 0–1 had
a success rate of greater than 90 % (97.8 and 92.3 % re-
spectively) and required a short time for wire crossing in
most cases. Success progressively falls with an increased
score with “difficult” -J-CTO score equal or greater than
3- lesions having a 73.3 % success rate and demanding a
prolonged time for crossing [63].
Traditional predictive factors of failure during recanali-
zation with conventional antegrade techniques do not
apply for the retrograde techniques. Factors such as lesion
length, severe calcification, severe tortuosity and side
branch at the CTO site are not shown to predict failure
with retrograde techniques. The only predictive factors o
failure seem to be related to collateral circulation charac-
teristics, such as the presence and quality of the collat-
erals, their continuity and tortuosity, their location in the
septum or in the epicardium, the angle of the collateral
anastomosis with the CTO vessel [64].
As the CTO PCI techniques driven by the techno-
logical advancements are evolving leading to continu-
ously improving outcomes, it is inevitable that the same
will happen with the predictive factors of success/failure.
Non-invasive imaging, in particular coronary Multi-
Slice Computed Tomography (MSCT), can also assist
the procedural planning by delineating the characteris-
tics of the CTO. A considerable number of operators
employ MSCT in order to assess: 1) the length and
three-dimensional course of the occluded arterial seg-
ment; 2) the presence of calcium at the CTO; 3) the
vessel size and remodeling (either positive or negative);
and 4) the quality of the vessel distal to the CTO d
shrinkage CTO [65–70].
Many studies have identified MSCT-related predictors of
failure such as occlusion length, calcification, negative re-
modeling and vessel bending and shrinkage CTO [65–70].
There are even studies identifying MSCT parameters pre-
dictive of adverse long-term clinical outcomes after CTO
PCI [24].
In the absence of randomized efficacy data and consider-
ations related to patient radiation exposure, the consensus
of the EuroCTO Club was that MSCT cannot be recom-
mended for routine pre-procedural imaging for CTO PCI,
but should be considered for complex CTO lesions with
expected success rate <50 % and in cases of repeat proce-
dures after initial CTO recanalization failure [17].
CTO recanalization techniques
There are three basic CTO recanalization techniques:
antegrade, retrograde and dissection reentry. In contem-
porary CTO treatment these techniques are complemen-
tary to each other and they can be alternatively applied
and combined as necessary (Fig. 1).
Antegrade techniques are cornerstone and one way or
another they are applied during a CTO recanalization pro-
cedure. It is widely accepted that they should be applied
first. Antegrade single wire technique over a dedicated
microcatheter is the simplest of all. There are two varia-
tions: the wire escalation approach (stiff-stiffer-stiffest)
and the “step up-step down” approach (stiff-soft-stiff).
The latter is used to accommodate hard or soft tissue
penetration and the potential angulation of the occluded
segment. In case of single wire technique failure, the par-
allel wire technique should be applied. The principle is to
keep the first wire in place (subintimal space) and advance
a second stiffer wire towards the distal true lumen using
the first wire as a marker (parallel wire technique, Fig. 2).
Retrograde techniques were revolutionized with the
introduction of CART (Controlled Antegrade Retrograde
subintimal Tracking) technique in 2005 by Katoh [71].
The novelty was the intentional collateral channel cross-
ing, mostly septal, the channel dilatation with 1.5 mm
balloons and the retrograde penetration and dilatation of
the occlusion, most often close to the distal cap to facili-
tate antegrade wire crossing (CART). The main disad-
vantage was the need for septal dilatation with short
balloons to allow passage of equipment resulting in com-
plications with the collateral channels. The advent of
dedicated microcatheters for collateral crossing, such as
the Corsair from Asahi and the Finecross from Terumo,
abolished the necessity for septal dilatation but also the
capacity for retrograde dilatation of the occlusion, shift-
ing the field to the Reverse-CART technique where bal-
loon dilatation involved the body of the occlusion close
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Fig. 1 The continuum of CTO PCI
Fig. 2 The Parallel Wire Technique. a: Right coronary artery (RCA) chronic total occlusion (CTO); blunt proximal stump and bifurcation at the CTO
site. b Contralateral contrast injection revealing CC2 septal and epicardial collaterals from the Left Anterior Descending (LAD) coronary artery. c
Bilateral contrast injection with the distal vessel opacified indicating a short and straight occluded segment. d, e To prevent dislodgment of the
guiding catheter while advancing wire and microcatheter through the occlusion, a 2.5 × 20 mm balloon is inflated in an atrial branch proximal to
the occlusion (anchoring technique). The wire (Fielder XT, Asahi Intecc, Japan) made progress through the body of the occlusion but appears to
have deflected from the target. f A Confianza Pro 12 wire (Asahi Intecc, Japan) supported by a Corsair microcatheter (Asahi Intecc, Japan) is
advanced towards the distal end of the occlusion parallel to the Fielder XT wire which is left in place. At the insert the distal segments of the two
wires. g Successful chronic total occlusion (CTO) crossing; dissection at the site of the occlusion after predilatation. g Final angiographic result
after implantation of 3.5 × 38 mm and 3.0 × 38 mm everolimus eluting stents with (Thrombolysis In Myocardial Infarction) TIMI III flow and no
residual stenosis
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to the proximal cap to facilitate retrograde wire crossing
[16]. As of today this technique dominated the field and
became the standard retrograde technique. In both tech-
niques the main principle is the connection of the ante-
grade and retrograde subintimal spaces and the more
recent development is the facilitation of this part of the
procedure with the use of guiding catheters extensions
(Guideliner, Vascular Solutions, Inc., Minneapolis,
Minnesota), and Guidezilla, Boston Scientific, USA) with
or without intravascular ultrasound (IVUS) use. After
that, the externalization of a long 330 cm 0.010 in.
(0.26 mm) diameter RG3 wire (Asahi Intec, Japan) is the
final step in most of these complex procedures, provid-
ing excellent back-up support and allowing antegrade
completion of the procedure (Fig. 3).
Dissection and reentry techniques are the evolutionary re-
finement of the STAR (Subintimal Tracking And Reentry)
technique introduced by Colombo [71]. The principle of
wire based dissection and reentry techniques is either ante-
grade or retrograde rapid steering of a stiff polymeric wire
in the subintimal space, knuckled within the body of the oc-
clusion. Knuckled wires tend to stay within the vessel archi-
tecture. These techniques are mainly used when there is
vessel ambiguity within the occluded segment or whenever
it is necessary for long arterial occluded segments to be
crossed safely and fast. In certain occasions soft polymeric
wires with small knuckles are used for dissection reentry
aiming in minimal vessel disruption, mainly antegrade
(mini-STAR technique). Device based dissection and
reentry employ a dedicated device for antegrade sub-
intimal space tracking (CrossBoss coronary catheter,
Boston Scientific, USA) and distal wire exit is facili-
tated by a dedicated flat balloon with lateral ports
(Sting-Ray, Boston Scientific, USA) [70].
Complimentary to these cornerstone techniques are ad-
junctive techniques such as balloon anchoring in side
branches for active guiding catheter support and trapping
of wires within guiding catheters to facilitate removal of
long microcatheters [17]. Intracoronary imaging with
IVUS and Optical Coherence Tomography (OCT) is also
an important addition for the facilitation of the abovemen-
tioned techniques. The success rate in dedicated centers
applying contemporary strategies remain in the field of
90 %, despite the escalating complexity of the lesions ad-
dressed over the last decade [68].
As of today the abovementioned techniques are well
described but there is a lack of published universal defi-
nitions. There is also no universal consensus on how
these techniques should be implemented and applied.
The American school has proposed the Hybrid algo-
rithm that describes a strategy of initial selection and
rapid switching from antegrade to retrograde approach
based on four simple questions related to CTO and col-
lateral anatomy-proximal cap ambiguity, distal target, le-
sion length, and presence of interventional collaterals
[72]. Such an algorithm is not widely adopted by Euro-
pean and even less by Japanese operators. Specifically
the last ones consider dissection and reentry techniques
non optimal approach for CTO recanalization, as there
are considerations related to adverse clinical outcomes
with their application, due to stenting of long subintimal
spaces. There is lack of data in the literature related to
Fig. 3 The Reverse Controlled Antegrade Retrograde Subintimal Tracking (CART) Technique. a Right coronary artery (RCA) with shepherd’s crook
morphology occluded proximally; severely calcified chronic total occlusion (CTO) with blunt stump. b Contralateral injection revealing retrograde
filling of the distal vessel via septal and epicardial collaterals. c After failure to cross the septal collaterals, switch to epicardial connections.
Selective contrast injection through a Corsair microcatheter (Asahi Intecc, Japan) better delineates the course of the epicardial collaterals from the
Left Circumflex Coronary (LCX) artery. d, e A tortuous continuous epicardial collateral (Werner CC2) is selected and crossed with a Fielder FC wire
(Asahi Intecc, Japan). f Corsair microcatheter advanced into the distal true lumen over the Fielder FC wire; selective contrast tip injection confirms
intraluminal position. g Retrograde wiring of the occlusion with a Gaia second wire (Asahi Intecc, Japan) and an Ultimate wire (Asahi Intecc,
Japan); vessel course ambiguity. h Bilateral wiring of the occlusion with a Gaia second wire antegradely and an Ultimate wire (Asahi Intecc, Japan)
retrogradely. i Retrograde wire knuckle in the subintimal space. j Antegrade balloon dilatations enlarging the subintimal space to facilitate
retrograde wire crossing (reverse CART technique). k Retrograde wire (Ultimate) crosses the lesion and enters the ascending aorta; the Corsair is
advanced through the body of the occlusion but the wire cannot be advanced in the antegrade guiding catheter. l Snaring of the retrograde
wire into the antegrade guiding catheter. m Advancement of the Corsair into the antegrade guiding catheter. n Externalization of an RG3 wire
(Asahi Intecc, Japan) allows antegrade insertion of balloons and stents. o Final angiographic result after implantation of 3.5 × 18 mm, 3.0 × 33 mm
and 2.75 × 38 mm everolimus eluting stents. p Contralateral injection revealing intact collateral circulation. o Bilateral Injection confirming
(Thrombolysis In Myocardial Infarction) TIMI III flow and no residual stenosis in the RCA
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the long term outcomes of CTO PCI with contemporary
techniques that needs to be further addressed.
CTO recanalization techniques have evolved in parallel
with the development of guidewire and microcatheter
technology. The milestones of CTO guidewire develop-
ment are presented in Table 1. The CTO wire toolbox
with different types of dedicated wires and the indicated
way of use is presented in Table 2 and other material
CTO toolbox is presented in Table 3. One of the most
frequently asked question is the sequence of wire selec-
tion in contemporary CTO techniques, both antegrade
and retrograde. Such a question cannot be addressed
based on individual wire suggestions as there is great
variability in preferences even among the most experi-
enced of the operators. What is important to be under-
stood is the interaction of different kind of guidewires
(soft < 1 gr, intermediate stiff 2–6 gr, stiff >9 gr) with dif-
ferent type of tissue (soft, hard and calcified). In general,
soft (<1gr) tapered polymeric composite core guidewires
are suitable for soft tissue tracking (passive wire control).
Intermediate stiff (2–6 g) tapered composite core guide-
wires are used for hard tissue tracking (active wire control)
and stiff (>9gr) tapered guidewires are suitable for calcified
tissue penetration.
Operator requirements and CTO PCI complications
Opening complex CTOs remains a challenge requiring a
certain learning curve before the operator becomes fa-
miliar and can be highly effective (>300 CTOs and >50
retrograde procedures per year), while simultaneously
keeping the procedure safe; specific proctorship and
guided training are indispensable elements in order to
obtain the success rates reported above [72]. The inci-
dence of complications remains low when these proce-
dures are performed by experienced operators and high
volume laboratories, despite the long procedural duration
and use of multiple aggressive wires and catheters [73].
Major concerns are radiation exposure and contrast usage
that are highly operator influenced and care should be
Table 1 Milestones in the CTO guidewire technology
Year Milestone Product
1995 Polymeric coating SCIMED
Choice PT
1996 Hydrophilic coating TERUMO
Crosswire
1997 Incremental tip load (drilling concept) ASAHI
Miracle
family (3.5
up to 12 gr)
1998 Tapered Tip Design GUIDANT
HT CROSS-
IT XT
1998 Combination of tapering with hydrophilic
coating in high tip stiffness (>9 gr)
(penetration concept)
ASAHI
Confianza/
Pro
2008 Combination of tapering with polymer and
hydrophilic coating in low tip stiffness (<1 gr)
(sliding concept)
ASAHI
Fielder XT
2010/
2011
Composite core tip in low tip stiffness ASAHI
SION/
Fielder
XTA/XTR
2013 Combination of composite core tapering polymeric
and hydrophilic coating in intermediate stiffness
(>1.5gr, <5 gr) (Deflection and rotation concept)
ASAHI GAIA
family
Table 2 The CTO wire toolbox
Tapered, soft (~1) plastic jacketed GW (XT/XT-A/XTR)
➢ Antegrade/Retrograde microchannel/soft plaque probing
➢ Facilitation of quick wiring Dissection Re-entry in abmbigous vessel
anatomy/soft plaque (Knuckle wire technique)
➢ Very small and tortuous collateral chanel crossing epicardial and
septal(retrograde access)
Non-tapered, soft plastic jacketed GW (Fielder FC/Pilot 50/Whisper)
➢ Multi-tasting (Mainly work in the body of the occlusion-getting less
fashionable)
Non tapered, medium gram force plastic jacketed wire (Pilot 150/200)
➢ Body of the occlusion
➢ Facilitation quick wiring in complex lesions and/or dissection-
reentry in ambiguous vessel anatomy
Non-tampered, soft, composite core, hydrophilic coated CW (SION)
➢ Multitasking
➢ Access to difficult take-off collaterals
➢ Crossing of non challenging collaterals channels
➢ Subintinal spaces connection and GC engagement in retrograde
techniques (CART/XCART)
Non-tapered, medium gram force (<6g), non coated, sliding wires
(Miracle 3/4.5/6)
➢ Used to be workhorse wires for lesion crossing-tend to be
abandoned
None-tapered, medium gram force (<6g), hydrophilic coated, sliding
wires (Miracle Ultimate)
➢ For lesion crossing (body of the occlusion) in hard but not severely
calcified plaques and non tortuous anatomy
Tapered, medium gram (<6g), composite core, hydrophilic coated GW
(GAIA family)
➢ Are becoming the workhorse wires for lesion crossing (body of the
occlusion) in the hard but not severely calcified plaques even in
tortuous anatomy
➢ Subintima space connection in Retrograde techniques
Tapered and not tapered w-w/o hydrophilic coating, high gram (>9)
GW penetration wires (Confianza fm, PROGRESS 200T)
➢ Crossing of severely calcified spots, exchanged to other categories
afterwards
Fielder FC (Asahi Intecc, Japan), Fielder XT (Asahi Intecc, Japan), Fielder XTA
(Asahi Intecc, Japan), Fielder XTR (Asahi Intecc, Japan), SION (Asahi Intecc,
Japan), Gaia 1st/2nd/3rd (Asahi Intecc, Japan), Miracle 3/4.5/6 (Asahi Intecc,
Japan), Miracle Ultimate (Asahi Intecc, Japan), Pilot 50/150/200 (Abbot
Vascular, USA), Confianza family (Asahi Intecc, Japan), Whisper (Abbot Vascular,
USA), Progress 200 T (Abbot Vascular, USA)
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taken to remain as low as possible [17]. Over long period
of time CTO PCI complications rates remain <2 %, com-
parable to complication rates of non-occlusive coronary
artery disease, and this seems to hold true also for ad-
vanced techniques and new dedicated guidewires [74–76].
Complications were significantly more likely to occur in
the elderly, in women and in patients with triple vessel
disease and depressed left ventricular function [74]. Wire
exits and dissections are not uncommon in these proce-
dures and are uneventful if promptly recognized and ad-
dressed. Drainage of pericardial tamponade and sealing of
perforations with covered stents or microcoils are very
rarely required but can be life-saving and the operator
should be familiar with their use. Periprocedural myocar-
dial injury, identified with systematic measurement of car-
diac biomarkers post-CTO PCI, ensues in 8.6 % of
patients, is more common with the retrograde approach,
and is associated with worse subsequent clinical outcomes
during mid-term follow-up [77].
Conclusion
Technical and procedural success rates for CTO PCI have
risen steadily over the last ten years, as a result of in-
creased operator experience, improved materials, the re-
finement of the antegrade approach and the introduction
of the retrograde approach, along with the development of
dedicated groups of experts focusing on technical devel-
opment, training and education worldwide. Data from
large national registries still report underutilization of PCI
for CTO, limited to 5–6 % of all the revascularization pro-
cedures and far below its prevalence [13, 78]. Further
technical development is needed to facilitate and simplify
the revascularization techniques, making them both safer
and more standardized and predictable. Further evidence,
ideally from randomized studies, of clinical benefit of
these inherently complex procedures may encourage oper-
ators and centers to engage in this challenging endeavor.
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